Dr Mark Tuthill is a consultant Medical Oncologist who specialises in the medical treatment of early and advanced cancers of the breast, prostate, kidney, and bladder.
He offers patients treatments with immunotherapy, chemotherapy, targeted therapies (cancer growth inhibitors), hormone based therapies and medicines to control symptoms.
As a cancer specialist, Dr Tuthill’s first priority is to ensure that you receive the most appropriate treatment to get you back to good health as quickly as possible.
Having a diagnosis of cancer can be a highly stressful and difficult time for patients and their families. There is often a wealth of information about cancer treatments that is easily accessible to patients and their relatives on the internet. Often many patients have some knowledge of the treatment that they may be offered. Dr Tuthill uses a compassionate patient centred approach to help each person and their family understand their illness and receive the very best possible treatment for their cancer. This gives patients the confidence to forward with their lives after a diagnosis of cancer. Whatever the diagnosis and treatment plan, the treatment can be tailored to your work and personal commitments to minimise disruption and restore your quality of life.
- Breast cancer
- Prostate cancer
- Kidney cancer
- Bladder cancer
Tumour immunology and personalised medicine
Spending time with family, reading the economist, and gardening.
Treatments and tests offered by Dr Mark Henry Tuthill at Nuffield Health
- CT scan (or CAT scan)
- Breast oncology
Dr Tuthill principle research interest is tumour immunology which is the study of how the immune system interacts with cancer cells. Treatments that harness the immune system to attack cancer cells have recently been shown to improve outcomes in many types of cancer including bladder cancer and kidney cancer. Dr Tuthill was awarded a prestigious Medical Research Council Research Fellowship to study for a PhD at Imperial College London. His research identified a new way of killing cancer cells without chemotherapy and was published in the cancer journal Oncogene. Dr Tuthill is the principle or sub investigator on a large number of clinical trials for the treatment of early and advanced cancer.
Dr Tuthill regularly attends national and
international cancer conferences to present his work and to keep abreast in the
many exciting developments in cancer medicine that are occurring. His research
and interactions with leading national and international cancer experts helps
him deliver the very best possible clinical care to the patients that he treats
- Association of cancer Physicians
- Medical Protection Society
Other posts held
- NHS consultant at the Churchill Hospital Oxford
Insurers Dr Mark Henry Tuthill works with
Dr Mark Henry Tuthill works with the following private medical insurance providers:
- Aviva Health
- AXA Health
- AXA - Global Healthcare
- Vitality Health (Pru Health)
Dr Mark Henry Tuthill does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Dr Mark Henry Tuthill does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.
Dr Mark Henry Tuthill does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.